Xoma reported $-4436000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 3179M 2413M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Ardelyx ARDX:US $ -43.59M 1.6M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Celldex Therapeutics CLDX:US $ -20.45M 7.08M
Chimerix CMRX:US $ -18.56M 0.8M
Curis CRIS:US $ -11.05M 0.21M
Eli Lilly And LLY:US $ 1110.1M 280.1M
Emergent Biosolutions EBS:US $ -32.7M 37.3M
Epizyme EPZM:US $ -65.83M 1.47M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Life Technologies LIFE:US $ -7.67M 2.72M
Macrogenics MGNX:US $ -52.89M 12.95M
Novartis NOVN:VX SF 2758M 138M
Novartis NVS:US $ 2758M 138M
Pfizer PFE:US $ 8146M 2582M
Prothena PRTA:US $ 109.25M 81.6M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Teva Pharmaceutical Industries TEVA:US $ 290M 83M
Xoma XOMA:US $ -4436000 2.2M
YTE INCY:US $ 181.74M 32.28M